Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-15

FDA Approved: LINCOCIN — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for LINCOCIN (lincomycin hydrochloride) from Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LINCOCIN (LINCOMYCIN HYDROCHLORIDE)

Snippet

SUPPL AP for LINCOCIN (LINCOMYCIN HYDROCHLORIDE)